CLOV vs DVAX · rev $1.37B vs rev $277.2M
Clover Health Investments Corp (CLOV) versus Dynavax Technologies Corporation (DVAX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
CLOV currently screens at market cap $1.55B. DVAX currently screens at market cap $1.82B.
Not investment advice. Open the CLOV and DVAX stock pages for the full models.
Not investment advice.